icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. E75.10
  4. Feedback

ICD-10 Code E75.10
Unspecified gangliosidosis

E75.10 is a medical classification code used for unspecified gangliosidosis, a rare inherited metabolic disorder characterized by the accumulation of gangliosides in tissues, most notably within the central nervous system. This group of lysosomal storage diseases stems from genetic mutations that cause deficiencies in specific enzymes responsible for breaking down lipids, leading to progressive cellular damage and severe neurological decline. Clinical manifestations often include neurodevelopmental regression, muscle weakness, hypotonia, seizures, vision and hearing loss, organomegaly, and a distinctive cherry-red spot on the macula. Related diseases and conditions within this spectral category include GM1 gangliosidosis, GM2 gangliosidosis, Tay-Sachs disease, Sandhoff disease, GM3 gangliosidosis, and Mucolipidosis IV.

Inclusion term(s):

  • Gangliosidosis NOS

E75.10 is a valid billable ICD-10 diagnosis code for Unspecified gangliosidosis. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.

Check for any exclusions, inclusions or special notations associated with E75.10


E75.10 also applies to the following:

Inclusion term(s):

  • Gangliosidosis NOS

The use of ICD-10 code E75.10 can also apply to:

  • Gangliosidosis
Coding structure:

ICD-10 code E75.10 is based on the following Tabular structure:

Chapter 4: Endocrine, nutritional and metabolic diseases
  • Section E70-E88: Metabolic disorders
    • Category E75: Disorders of sphingolipid metabolism and other lipid storage disorders

↑ Parent code:
E75.1 for Other and unspecified gangliosidosis

E75.10__
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use E75.10 or E7510 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section E70-E88 — Metabolic disorders

Excludes1

  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan syndrome (Q87.4-)
  • 5-alpha-reductase deficiency (E29.1)

Excludes2

  • Ehlers-Danlos syndromes (Q79.6-)
  1. E75 Disorders of sphingolipid metabolism and other lipid storage disorders

    Excludes1

    • mucolipidosis, types I-III (E77.0-E77.1)
    • Refsum's disease (G60.1)
    1. E75.0 GM2 gangliosidosis

      1. E75.00 GM2 gangliosidosis, unspecified

      2. E75.01 Sandhoff disease

      3. E75.02 Tay-Sachs disease

      4. E75.09 Other GM2 gangliosidosis

        Inclusion term(s):

        • Adult GM2 gangliosidosis
        • Juvenile GM2 gangliosidosis
    2. E75.1 Other and unspecified gangliosidosis

      1. E75.10 Unspecified gangliosidosis

        Inclusion term(s):

        • Gangliosidosis NOS
      2. E75.11 Mucolipidosis IV

      3. E75.19 Other gangliosidosis

        Inclusion term(s):

        • GM1 gangliosidosis
        • GM3 gangliosidosis
    3. E75.2 Other sphingolipidosis

      1. E75.21 Fabry (-Anderson) disease

      2. E75.22 Gaucher disease

      3. E75.23 Krabbe disease

      4. E75.24 Niemann-Pick disease

        Inclusion term(s):

        • Acid sphingomyelinase deficiency (ASMD)
        • E75.240 Niemann-Pick disease type A

          Inclusion term(s):

          • Acid sphingomyelinase deficiency type A (ASMD type A)
          • Infantile neurovisceral acid sphingomyelinase deficiency
        • E75.241 Niemann-Pick disease type B

          Inclusion term(s):

          • Acid sphingomyelinase deficiency type B (ASMD type B)
          • Chronic visceral acid sphingomyelinase deficiency
        • E75.242 Niemann-Pick disease type C
        • E75.243 Niemann-Pick disease type D
        • E75.244 Niemann-Pick disease type A/B

          Inclusion term(s):

          • Acid sphingomyelinase deficiency type A/B (ASMD type A/B)
          • Chronic neurovisceral acid sphingomyelinase deficiency
        • E75.248 Other Niemann-Pick disease
        • E75.249 Niemann-Pick disease, unspecified

          Inclusion term(s):

          • Acid sphingomyelinase deficiency (ASMD) NOS
      5. E75.25 Metachromatic leukodystrophy

      6. E75.26 Sulfatase deficiency

        Inclusion term(s):

        • Multiple sulfatase deficiency (MSD)
      7. E75.27 Pelizaeus-Merzbacher disease

      8. E75.28 Canavan disease

      9. E75.29 Other sphingolipidosis

        Inclusion term(s):

        • Farber's syndrome
        • Sulfatide lipidosis
    4. E75.3 Sphingolipidosis, unspecified

    5. E75.4 Neuronal ceroid lipofuscinosis

      Inclusion term(s):

      • Batten disease
      • Bielschowsky-Jansky disease
      • Kufs disease
      • Spielmeyer-Vogt disease
    6. E75.5 Other lipid storage disorders

      Inclusion term(s):

      • Cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein]
      • Wolman's disease
    7. E75.6 Lipid storage disorder, unspecified

Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings